Rare Disease Week

TMA will be participating in Rare Disease Week on Capitol Hill February 24th- February 28th hosted by Rare Disease Legislative Advocates (RDLA). During Rare Disease Week on Capitol Hill 2019, RDLA plans to bring together over 500 patient advocates in Washington, DC for a week of events dedicated to empowering patients, families, friends, and healthcare professionals to become…

Continue Reading
Mother and Daughter Hugging

Lenabasum in dermatomyositis clinical trial

Corbus Pharmaceuticals is now recruiting dermatomysitis patients for an exciting phase 3 clinical trial for lenabasum. The trial, known as DETERMINE, is designed to evaluate the efficacy and safety of lenabasum for the treatment of dermatomyositis.

Continue Reading

New medical advisors appointed

The Myositis Association (TMA), the leading international patient organization dedicated to improving the lives of people affected by myositis, is pleased to announce the appointment of the following individuals to its distinguished Medical Advisory Board:

Continue Reading